Verona Pharma PLC ADR (VRNA) Insider Trading
- $567,802.24
- $143,638,415.76
- Aug. 1, 2025
- David Zaccardelli
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 1, 2025 | Director | 824 | $13.14 | Sell | $10,827.36 | |
Aug. 1, 2025 | Director | 4,328 | $13.14 | Sell | $56,869.92 | |
Aug. 1, 2025 | Director | 10,808 | $13.14 | Sell | $142,017.12 | |
Aug. 1, 2025 | CFO | 208,912 | $13.14 | Sell | $2,745,103.68 | |
Aug. 1, 2025 | Director | 1,808 | $13.14 | Sell | $23,757.12 | |
Aug. 1, 2025 | Insider | 58,336 | $13.14 | Sell | $766,535.04 | |
Aug. 1, 2025 | General Counsel | 9,584 | $13.14 | Sell | $125,933.76 | |
Aug. 1, 2025 | Director | 10,808 | $13.14 | Sell | $142,017.12 | |
Aug. 1, 2025 | Director | 3,608 | $13.14 | Sell | $47,409.12 | |
Aug. 1, 2025 | CEO | 208,912 | $13.14 | Sell | $2,745,103.68 | |
Aug. 1, 2025 | Director | 11,288 | $13.14 | Sell | $148,324.32 | |
Aug. 1, 2025 | Director | 9,464 | $13.14 | Sell | $124,356.96 | |
Aug. 1, 2025 | Director | 1,904 | $13.14 | Sell | $25,018.56 | |
June 16, 2025 | General Counsel | 80,000 | $11.53 | Sell | $922,400.00 | |
June 11, 2025 | CFO | 400,000 | $11.40 | Sell | $4,560,000.00 | |
June 11, 2025 | CEO | 400,000 | $11.40 | Sell | $4,560,000.00 | |
May 29, 2025 | CEO | 208,696 | $9.33 | Sell | $1,947,133.68 | |
May 29, 2025 | CFO | 204,864 | $9.33 | Sell | $1,911,381.12 | |
May 28, 2025 | CFO | 162,704 | $9.30 | Sell | $1,513,147.20 | |
May 28, 2025 | CEO | 157,704 | $9.30 | Sell | $1,466,647.20 | |
May 27, 2025 | CEO | 33,600 | $9.53 | Sell | $320,208.00 | |
May 27, 2025 | CFO | 32,432 | $9.53 | Sell | $309,076.96 | |
May 6, 2025 | Insider | 114,984 | $8.82 | Sell | $1,014,158.88 | |
April 29, 2025 | CEO | 90,360 | $8.98 | Sell | $811,432.80 | |
April 29, 2025 | Insider | 34,384 | $8.98 | Sell | $308,768.32 | |
April 29, 2025 | Director | 20,000 | $8.92 | Sell | $178,400.00 | |
April 29, 2025 | General Counsel | 26,072 | $8.98 | Sell | $234,126.56 | |
March 12, 2025 | Insider | 79,264 | $8.35 | Sell | $661,854.40 | |
Dec. 6, 2024 | CEO | 162,800 | $5.01 | Sell | $815,628.00 | |
Dec. 6, 2024 | CFO | 183,728 | $5.01 | Sell | $920,477.28 | |
Dec. 4, 2024 | CEO | 67,608 | $5.00 | Sell | $338,040.00 | |
Dec. 4, 2024 | CFO | 58,184 | $5.00 | Sell | $290,920.00 | |
Dec. 2, 2024 | CFO | 1,600 | $5.00 | Sell | $8,000.00 | |
Dec. 2, 2024 | CEO | 3,200 | $5.00 | Sell | $16,000.00 | |
Nov. 29, 2024 | CEO | 98,888 | $5.01 | Sell | $495,428.88 | |
Nov. 29, 2024 | CFO | 98,704 | $5.01 | Sell | $494,507.04 | |
Nov. 27, 2024 | CEO | 23,240 | $5.00 | Sell | $116,200.00 | |
Nov. 27, 2024 | CFO | 12,936 | $5.00 | Sell | $64,680.00 | |
Nov. 25, 2024 | CFO | 1,600 | $5.00 | Sell | $8,000.00 | |
Nov. 25, 2024 | Insider | 240,000 | $4.90 | Sell | $1,176,000.00 | |
Nov. 11, 2024 | CEO | 2,400 | $5.00 | Sell | $12,000.00 | |
Nov. 6, 2024 | Director | 39,360 | $4.80 | Buy | $188,928.00 | |
Nov. 4, 2024 | CFO | 80,784 | $4.39 | Sell | $354,641.76 | |
Nov. 4, 2024 | CEO | 94,144 | $4.39 | Sell | $413,292.16 | |
Nov. 1, 2024 | CFO | 48,888 | $4.38 | Sell | $214,129.44 | |
Nov. 1, 2024 | CEO | 46,888 | $4.38 | Sell | $205,369.44 | |
Oct. 25, 2024 | CEO | 4,800 | $4.38 | Sell | $21,024.00 | |
Oct. 24, 2024 | CFO | 141,360 | $4.38 | Sell | $619,156.80 | |
Oct. 23, 2024 | CEO | 16 | $4.38 | Sell | $70.08 | |
Oct. 21, 2024 | CFO | 116,696 | $4.38 | Sell | $511,128.48 |
Insiders are both buying and selling Verona Pharma PLC ADR stock.
The insider traders at Verona Pharma PLC ADR are: David Zaccardelli, Mark W Hahn, Kathleen A Rickard, Claire Poll, David R Ebsworth, Andrew Fisher, Orbimed Advisors Llc, Lisa Deschamps, Anders Ullman, Martin Edwards, Vikas Sinha, James Aloysius Brady, Mark W. Hahn, Christina Ackermann, Michael Austwick, Kenneth Cunningham, and Mahendra Shah
The most active insider trader at Verona Pharma PLC ADR is David Zaccardelli with 31 trades.
Orbimed Advisors Llc has sold the most Verona Pharma PLC ADR stock with a total value of $102,642,802.00.
David R Ebsworth has bought the most Verona Pharma PLC ADR stock with a total value of $694,656.00.
The most recent insider trade for Verona Pharma PLC ADR was on Aug. 1, 2025.
The single biggest insider buy for Verona Pharma PLC ADR was from David R Ebsworth with a total value of $316,800.00 on Nov. 6, 2023.
The single biggest insider sell for Verona Pharma PLC ADR was from Orbimed Advisors Llc with a total value of $86,415,927.92 on Dec. 22, 2022.